Načítá se...
Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease worldwide. However, there is no available therapy reversing the neurodegenerative process of PD. Based on the loss of dopamine or dopaminergic dysfunction in PD patients, most of the current therapies focus on s...
Uloženo v:
| Vydáno v: | Acta Pharmacol Sin |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Singapore
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7471472/ https://ncbi.nlm.nih.gov/pubmed/32112042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-0365-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|